Crypto News

1 hour ago

Moderna (MRNA) Stock Reaches New 52-Week Peak Amid Cancer Treatment Breakthroughs

Stocks

Moderna (MRNA) reached a 52-week high as CEO Bancel emphasized the company's mRNA platform capabilities beyond COVID vaccines, spotlighting cancer treatment.

The post Moderna (MRNA) Stock Reaches New 52-Week Peak Amid Cancer Treatment Breakthroughs appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$BMNR10-Year Yield24/7 trading30-Year Yield4-Year Cycle50-Week Moving AverageAB 2409AGIXAIAI IPO marketAI InfrastructureAI bubbleAI capital rotationAI spendingAMD StockAMLAML complianceAMM Liquidity PoolsAMZN StockAPT

Latest News